Central Sensitization, Pain, and Psychosocial Factors in Individuals with Lipedema: A Cross-Sectional Study
Aesthetic Plastic Surgery · 2026
DOI: 10.1007/s00266-026-05957-2 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Aesthetic Plastic Surgery, 2026. Verfasst von Büşra Şirin Ahısha und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences, Istanbul Physical Medicine and Rehabilitation Education and Research Hospital, Istanbul, Turkey. bsrn080@gmail.com. Hauptthemen laut MEDLINE: Pain Threshold, Central Nervous System Sensitization, Lipedema. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Health Sciences, Istanbul Physical Medicine and Rehabilitation Education and Research Hospital, Istanbul, Turkey. bsrn080@gmail.com.
- University of Health Sciences, Istanbul Physical Medicine and Rehabilitation Education and Research Hospital, Istanbul, Turkey.
- University of Health Sciences, Bakırkör Dr Sadi Konuk Education and Research Hospital, Istanbul, Turkey.
Zitieren
APA
Şirin Ahısha, B., Kesiktaş, N., Paker, N., Ersoy, S., & Ahısha, Y. C. (2026). Central Sensitization, Pain, and Psychosocial Factors in Individuals with Lipedema: A Cross-Sectional Study. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-026-05957-2
Vancouver
Şirin Ahısha B, Kesiktaş N, Paker N, Ersoy S, Ahısha YC. Central Sensitization, Pain, and Psychosocial Factors in Individuals with Lipedema: A Cross-Sectional Study. Aesthetic Plastic Surgery. 2026. doi:10.1007/s00266-026-05957-2
BibTeX
@article{irinAhsha2026,
author = {Şirin Ahısha, Büşra and Kesiktaş, Nur and Paker, Nurdan and Ersoy, Sedef and Ahısha, Yiğit Can},
title = {Central Sensitization, Pain, and Psychosocial Factors in Individuals with Lipedema: A Cross-Sectional Study},
journal = {Aesthetic Plastic Surgery},
year = {2026},
doi = {10.1007/s00266-026-05957-2}
}
EUVIMED